A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts

Affiliations

• ¹ Department of Haematology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
• ² Centre de Recherche en Cancérologie de Lyon - INSERM U 1052/CNRS UMR 5286/Centre Léon Bérard, Lyon, France.
• ³ Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
• ⁴ Department of Haematology, Hôpital Le Bocage-CHU Dijon, Dijon, France.
• ⁵ International Agency for Research on Cancer (IARC), Lyon, France.
• ⁶ Division of Haematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
• ⁷ MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
• ⁸ Department of Haematology, CHU Nancy-Brabois, Vandoeuvre, France.
• ⁹ Department of Haematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker, Paris, France.
• ¹⁰ Lymphoid Malignancies Unit, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil, France.
• ¹¹ University of Iowa, Holden Comprehensive Cancer Center, Iowa City, IA, USA.
• ¹² Department of Pathology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker, Paris, France.
• ¹³ Department of Laboratory Medicine and Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
• ¹⁴ USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.